NCT00107887View on ClinicalTrials.gov

TB (Tuberculosis) Preventive Therapy for HIV Patients With Access to HAART (Highly Active Antiretroviral Therapy)

PHASE4CompletedINTERVENTIONAL
Enrollment

17,415

Participants

Timeline

Start Date

June 30, 2005

Primary Completion Date

December 31, 2010

Study Completion Date

December 31, 2010

Conditions
TuberculosisHIV Infections
Interventions
DRUG

INH preventive therapy

Clinics will receive training regarding the use of IPT for prevention of Tuberculosis

DRUG

TST (tuberculin skin test)

Clinics will be trained in the use of TST for assessing exposure to TB

Trial Locations (1)

20211-110

City of Rio De Janeiro Health Department Clinics, Rio de Janeiro

All Listed Sponsors
collaborator

Consortium to Respond Effectively to the AIDS/Tuberculosis Epidemic

OTHER

collaborator

Communicable Disease Program, Brazil

OTHER_GOV

collaborator

Bill and Melinda Gates Foundation

OTHER

lead

Johns Hopkins University

OTHER

NCT00107887 - TB (Tuberculosis) Preventive Therapy for HIV Patients With Access to HAART (Highly Active Antiretroviral Therapy) | Biotech Hunter | Biotech Hunter